Showing 821 - 840 results of 2,284 for search '"Cardiovascular disease"', query time: 0.09s Refine Results
  1. 821

    Peroxisome Proliferator-Activated Receptor γ and PGC-1α in Cancer: Dual Actions as Tumor Promoter and Suppressor by Seong-Hoon Yun, Sang-Heum Han, Joo-In Park

    Published 2018-01-01
    “…The role of PGC-1α in diabetes, neurodegeneration, and cardiovascular disease is particularly well known. PGC-1α is also now known to play important roles in cancer, independent of the role of PPARγ in cancer. …”
    Get full text
    Article
  2. 822

    Monocytes as Regulators of Inflammation and HIV-Related Comorbidities during cART by Joshua J. Anzinger, Tiffany R. Butterfield, Thomas A. Angelovich, Suzanne M. Crowe, Clovis S. Palmer

    Published 2014-01-01
    “…Here we examine markers and sources of monocyte activation during cART-treated HIV infection and discuss the role of monocytes during cardiovascular disease, HIV-associated neurocognitive disorder, and innate immune aging.…”
    Get full text
    Article
  3. 823

    Selenium in cancer management: exploring the therapeutic potential by Lingwen He, Lu Zhang, Yulong Peng, Zhijun He, Zhijun He

    Published 2025-01-01
    “…Prolonged selenium deficiency has been conclusively linked to an elevated risk of various diseases, including but not limited to cancer, cardiovascular disease, inflammatory bowel disease, Keshan disease, and acquired immunodeficiency syndrome. …”
    Get full text
    Article
  4. 824

    Role of PPARα and Its Agonist in Renal Diseases by Ching-Feng Cheng, Hsi-Hsien Chen, Heng Lin

    Published 2010-01-01
    “…In clinical application, PPAR-α activators, such as hypolipidemic drugs in fibric acid class, were proven to have therapeutic effects on metabolic syndrome and cardiovascular disease. This paper focuses on signaling pathways, ligand selectivity, and physio-pathological roles of PPARα in kidney diseases and the therapeutic utility of PPARα modulators in the treatment of diabetes and inflammation-induced nephropathy. …”
    Get full text
    Article
  5. 825

    Nano Delivery System for Atherosclerosis by Zhuoyi Rong, Xuan He, Tianjian Fan, Haitao Zhang

    Published 2024-12-01
    “…Atherosclerosis, a pathological process propelled by inflammatory mediators and lipids, is a principal contributor to cardiovascular disease incidents. Currently, drug therapy, the primary therapeutic strategy for atherosclerosis, faces challenges such as poor stability and significant side effects. …”
    Get full text
    Article
  6. 826

    Provide a method to diagnose and optimize diabetes using data mining methods and firefly algorithm by Reza Molaee Fard

    Published 2023-09-01
    “…The use of data mining methods can help in the early diagnosis of diabetes, which prevents the progression of this disease and many of its complications such as cardiovascular disease, vision problems and kidney disease. …”
    Get full text
    Article
  7. 827

    Clinical approach to palpitations in pregnancy by Ferha Saeed, Kirun Gunganah, Anna S. Herrey

    Published 2025-01-01
    “…Patients with structural or functional abnormalities or inherited cardiovascular disease are more likely to develop arrhythmia, especially during pregnancy when the mother’s body undergoes extensive physiological adaptations, which further contribute to an increased arrhythmia risk. …”
    Get full text
    Article
  8. 828

    Microgravity and Cardiovascular Health in Astronauts: A Narrative Review by John Azariah, Umberto Terranova

    Published 2025-01-01
    “…Conclusions While a direct link between microgravity and cardiovascular disease, such as coronary heart disease and myocardial infarction, remains elusive, the documented physiological changes pose a potential threat to the astronauts' health. …”
    Get full text
    Article
  9. 829

    Physical Activity: Exploring Views of Older Russian-Speaking Slavic Immigrants by Janet Purath, Catherine Van Son, Cynthia F. Corbett

    Published 2011-01-01
    “…Many of the 1.3 million Russian-speaking immigrants in the US have chronic conditions such as cardiovascular disease, diabetes, obesity, and depression. …”
    Get full text
    Article
  10. 830

    Diverse Roles of Macrophages in Atherosclerosis: From Inflammatory Biology to Biomarker Discovery by Ting Gui, Aiko Shimokado, Yujing Sun, Takashi Akasaka, Yasuteru Muragaki

    Published 2012-01-01
    “…Cardiovascular disease, a leading cause of mortality in developed countries, is mainly caused by atherosclerosis, a chronic inflammatory disease. …”
    Get full text
    Article
  11. 831

    Mechanisms and active substances of targeting lipid peroxidation in ferroptosis regulation by Hui Chen, Lingli Chen, Wenjun Wang

    Published 2024-09-01
    “…Ferroptosis is a novel form of cell death driven by iron-dependent lipid peroxidation and it is implicated in various diseases, such as liver disease, acute kidney injury, cardiovascular disease, neurodegenerative disease and cancer. …”
    Get full text
    Article
  12. 832

    Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros by Konstantinos Makrilakis, Stavros Liatis

    Published 2017-01-01
    “…Although it frequently coexists with other cardiovascular disease (CVD) risk factors, it confers an increased risk for CVD events on its own. …”
    Get full text
    Article
  13. 833

    Physical Activity and Arterial Stiffness: A Narrative Review by Jinyu Yang, Xiaoqian Chen, Xiang Chen, Lihua Li

    Published 2025-01-01
    “…ABSTRACT Arterial stiffness is a significant predictor of cardiovascular disease and mortality. Physical activity (PA) has been extensively studied for its potential to reduce arterial stiffness, but the relationship between different types, durations, and intensities of PA and arterial stiffness remains a topic of ongoing research. …”
    Get full text
    Article
  14. 834

    Cross-Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity by Jin Bu, Zhaohui Wang

    Published 2018-01-01
    “…Considering the prevalence of cardiovascular disease (CVD), significant interest has been focused on the gut microbiota-heart interaction because the gut microbiota has been recognized as a barometer of human health. …”
    Get full text
    Article
  15. 835

    RETRACTED ARTICLE: Navigating the crossroads: cardiometabolic risks in cancer survivorship – a comprehensive review by Arif Albulushi, Aisha Al Balushi, Muhhamed Shahzad, Ismail Al Bulushi, Hatim Al Lawati

    Published 2024-08-01
    “…Furthermore, we discuss the outcome implications of these cardiometabolic risk factors on cardiovascular disease development, future cardiovascular events, and overall survival, supported by studies showing improved outcomes through exercise and risk factor control.…”
    Get full text
    Article
  16. 836

    Acorn Oil: Chemistry and Functionality by Mehdi Taib, Lahboub Bouyazza, Badiaa Lyoussi

    Published 2020-01-01
    “…Diets enriched with acorn oil can be beneficial in preventing cardiovascular disease (CVD), cancer, and type 2 diabetes as well as offer antioxidant activity. …”
    Get full text
    Article
  17. 837

    Sarcopenia: A Major Challenge in Elderly Patients with End-Stage Renal Disease by Maciej Domański, Kazimierz Ciechanowski

    Published 2012-01-01
    “…If it cannot be treated with the simple methods requiring some knowledge and devotion, we will fail to save patients who die due to cardiovascular disease and infection, despite proper conduction of renal replacement therapy. …”
    Get full text
    Article
  18. 838

    The application of procyanidins in diabetes and its complications: a review of preclinical studies by Yongchuang Zhang, Mengna Li, Haoyuan Liu, Yongfu Fan, Huan Huan Liu

    Published 2025-02-01
    “…Diabetes mellitus (DM) and its various complications, including diabetic nephropathy, retinopathy, neuropathy, cardiovascular disease, and ulcers, pose significant challenges to global health. …”
    Get full text
    Article
  19. 839

    Persistent organochlorine pesticides and cardiometabolic outcomes among middle-aged Latina women in a California agricultural community: The CHAMACOS Maternal Cognition Study by Marcella Warner, Stephen Rauch, Brenda Eskenazi, Lucia Calderon, Robert B. Gunier, Katherine Kogut, Nina Holland, Weihong Guo, Julianna Deardorff, Jacqueline M. Torres

    Published 2025-02-01
    “…Objective: Environmental exposure to endocrine disrupting compounds is hypothesized to increase risk of cardiovascular disease through effects on obesity, hypertension, dyslipidemia, and insulin resistance. …”
    Get full text
    Article
  20. 840

    Association of Estimated Glomerular Filtration Rate (eGFR) and High-Sensitivity C-Reactive Protein (Hs-CRP) with the Risk of New-Onset Atrial Fibrillation in Patients with Diabetes by Liu Y, Liu H, Sun D, Zheng Y, Tse G, Chen K, Qiu J, Wu S, Liu T

    Published 2025-01-01
    “…Ying Liu,1,* Hongmin Liu,1,2,* Dongkun Sun,1,* Yi Zheng,1 Gary Tse,1,3,4 Kangyin Chen,1 Jiuchun Qiu,1 Shouling Wu,2 Tong Liu1 1Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, People’s Republic of China; 2Department of Cardiology, Kailuan General Hospital, Tangshan, 063001, People’s Republic of China; 3School of Nursing and Health Sciences, Hong Kong Metropolitan University, Hong Kong, People’s Republic of China; 4Diabetes Research Unit, Cardiovascular Analytics Group, PowerHealth Research Institute, Hong Kong, People’s Republic of China*These authors contributed equally to this workCorrespondence: Tong Liu, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, No. 23 Pingjiang Road, Hexi District, Tianjin, 300211, People’s Republic of China, Email liutong@tmu.edu.cn; liutongdoc@126.com Shouling Wu, Department of Cardiology, Kailuan General Hospital, Tangshan, 063001, People’s Republic of China, Email drwusl@163.comBackground: Both renal function decline and systemic inflammation may synergistically increase the risk of atrial fibrillation (AF). …”
    Get full text
    Article